We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Tobacco Biomarkers Detected in Smokers' Breath

By LabMedica International staff writers
Posted on 01 Jun 2010
A device analyzes individuals' breath samples to determine whether they had smoked during the previous three days.

Scientists designed an apparatus to analyze 0.8-L breath samples, whereas commercial analyzers require 2 L. More...
The device utilized an adsorption microtrap, which could release fluid in less than one second during the phase of desorption and did not require a second cryogenic trap.

A chemical compound in the breath of smokers indicated that they had smoked within the last three days. The chemical is not present in nonsmokers' breath unless they have been in contact with tobacco smoke for extended periods of time. Biomarkers of exposure are chemicals found in the body providing evidence of environmental exposure to that chemical or to a precursor chemical.

Breath samples from 100 smokers and 104 nonsmokers were analyzed by scientists at the University of Girona, (UdG; Gerona, Spain). The study participants, 147 females and 57 males, aged between 16 to 53 years, were also questioned about their lifestyle. The levels of benzene, 2,5-dimethylfuran, toluene, o-xylene, and m-p-xylene were measured using a new micro-trap system coupled with gas chromatography–mass spectrometry.

Benzene was only an effective biomarker for medium and heavy smokers, and its level was affected by smoking habits. The volatile organic compound 2,5-dimethylfurane was the only chemical found in smokers' breath 72 hours after they had inhaled tobacco smoke independent of smoking habits, such as short or long term exposure, light or heavy consumption. The scientists were able to detect 2,5-dimethylfuran in 12 breath samples of nonsmokers, who when questioned more thoroughly, were in fact social or weekend smokers.

Juan Manuel Sánchez Ph.D., of the chemistry department, UdG, stated that the method would be particularly useful to assess tobacco-related exposure in patients who do not admit to smoking or minimize their intake to their physicians. Smoking is well known risk factor for several pathological conditions including vascular and lung diseases.

The study was published online in February 2010 in Analytical and Bioanalytical Chemistry. The investigation is continuing and the technique is undergoing further development and improvement.

Related Links:

University of Girona




Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: DNlite measures urinary post-translationally modified Fetuin-A (uPTM-FetA), a biomarker linked to kidney stress, inflammation, metabolic dysfunction, and progressive renal injury (Photo courtesy of Bio Preventive Medicine Corp)

Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures

Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.